These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19888041)

  • 1. Retained placenta in homozygous sickle cell disease.
    Simms-Stewart D; Thame M; Hemans-Keen A; Hambleton I; Serjeant GR
    Obstet Gynecol; 2009 Oct; 114(4):825-828. PubMed ID: 19888041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms of low birth weight in infants of mothers with homozygous sickle cell disease.
    Thame M; Lewis J; Trotman H; Hambleton I; Serjeant G
    Pediatrics; 2007 Sep; 120(3):e686-93. PubMed ID: 17766509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is epidural analgesia during labor related to retained placenta?
    Sarit A; Sokolov A; Many A
    J Perinat Med; 2016 May; 44(4):415-9. PubMed ID: 25741732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the third stage of labor in second-trimester deliveries: How long is too long?
    Behrens JA; Greer DM; Kram JJF; Schmit E; Forgie MM; Salvo NP
    Eur J Obstet Gynecol Reprod Biol; 2019 Jan; 232():22-29. PubMed ID: 30458426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of pregnancy weight gain in homozygous sickle cell disease and effect on birth size.
    Thame M; Lewis J; Hambleton I; Trotman H; Serjeant G
    West Indian Med J; 2011 Jan; 60(1):36-40. PubMed ID: 21809709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of pregnancy in homozygous sickle cell disease.
    Serjeant GR; Loy LL; Crowther M; Hambleton IR; Thame M
    Obstet Gynecol; 2004 Jun; 103(6):1278-85. PubMed ID: 15172865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The third stage of labor: a study of outcomes in the second trimester of pregnancy.
    Childress KM; Holloran-Schwartz MB; Wuebker H; Gavard J; Blaskiewicz R
    J Reprod Med; 2014; 59(7-8):348-54. PubMed ID: 25098024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of the second stage of labor and preterm delivery risk in the subsequent pregnancy.
    Quiñones JN; Gómez D; Hoffman MK; Ananth CV; Smulian JC; Skupski DW; Fuchs KM; Scorza WE;
    Am J Obstet Gynecol; 2018 Nov; 219(5):467.e1-467.e8. PubMed ID: 30170038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpartum retained products of conception: Retrospective analysis of the association with third stage of labor placental complications.
    Smorgick N; Ayashi N; Levinsohn-Tavor O; Wiener Y; Betser M; Maymon R
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():108-111. PubMed ID: 30682599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reoccurrence of retained placenta at vaginal delivery: an observational study.
    Nikolajsen S; Løkkegaard EC; Bergholt T
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):421-5. PubMed ID: 22882191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for a prolonged third stage of labor and postpartum hemorrhage.
    Magann EF; Lutgendorf MA; Keiser SD; Porter S; Siegel ER; McKelvey SA; Morrison JC
    South Med J; 2013 Feb; 106(2):131-5. PubMed ID: 23380748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary outcomes of sickle cell disease in pregnancy.
    Kuo K; Caughey AB
    Am J Obstet Gynecol; 2016 Oct; 215(4):505.e1-5. PubMed ID: 27242200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of infant and maternal sickle cell disease on birth outcome and neonatal course.
    Brown AK; Sleeper LA; Pegelow CH; Miller ST; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1156-62. PubMed ID: 7921116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births.
    Alayed N; Kezouh A; Oddy L; Abenhaim HA
    J Perinat Med; 2014 Jul; 42(4):487-92. PubMed ID: 24344096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematological risk factors for pregnancy outcome in Jamaican women with homozygous sickle cell disease.
    Morris JS; Dunn DT; Poddar D; Serjeant GR
    Br J Obstet Gynaecol; 1994 Sep; 101(9):770-3. PubMed ID: 7524646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, Eastern Saudi Arabia.
    Al Jama FE; Gasem T; Burshaid S; Rahman J; Al Suleiman SA; Rahman MS
    Arch Gynecol Obstet; 2009 Nov; 280(5):793-7. PubMed ID: 19271230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome in homozygous sickle cell disease: observations from the Jamaican Birth Cohort.
    Lewis G; Thame M; Howitt C; Hambleton I; Serjeant GR
    BJOG; 2021 Sep; 128(10):1703-1710. PubMed ID: 33683802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of retained placenta: oxytocin as an independent risk factor.
    Endler M; Grünewald C; Saltvedt S
    Obstet Gynecol; 2012 Apr; 119(4):801-9. PubMed ID: 22433344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia.
    Sun PM; Wilburn W; Raynor BD; Jamieson D
    Am J Obstet Gynecol; 2001 May; 184(6):1127-30. PubMed ID: 11349177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
    Addai FK; Wilson JB; Quashie FJ
    Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.